QTY Code Platform
Cytokine Receptor Research/Therapeutic Discovery
Key Facts
Indication
Cytokine Receptor Research/Therapeutic Discovery
Phase
Preclinical
Status
Platform Validation
Company
About Avalon GloboCare
Avalon GloboCare is a commercial-stage biotech focused on precision diagnostics and cell therapy, with a mission to bridge research and commercialization. Its core assets include the FDA-cleared KetoAir™ breathalyzer for metabolic monitoring and the QTY Code protein design platform developed with MIT. The company's strategy involves leveraging these platforms while diversifying into AI-driven media technology, though this creates a bifurcated focus between healthcare and tech.
View full company profile